Improving support for our patients across Australia.
3 February 2020
Melanoma Institute Australia has recently partnered with three other organisations to boost support for melanoma patients and their carers across Australia.
Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA) have announced a new multi-year agreement to provide enhanced support services for patients nationally.
The new MPA/MIA agreement will focus on the introduction of a Tele Health Nurse Pilot Program to provide better access of services for melanoma patients; increasing the capacity and expertise of MPA’s Peer to Peer volunteer facilitators and volunteer support staff; enhancing face to face support groups within NSW and integration of these into MPA’s national support network; and joint involvement in events including patient information sessions and MIA’s national Melanoma March campaign.
With survival rates continuing to improve, the need for this collaboration to strengthen the support services available to our patients and families, is, thankfully, even greater. ’ Victoria Beedle, CEO of Melanoma Patients Australia
Melanoma patients and their families throughout the Riverina region will also benefit from strengthened and sustained melanoma services with the merger of Amie St Clair and Melanoma Institute Australia. It will provide immediate benefits by doubling the level of services provided to melanoma patients in the Riverina, including increased capacity of the free melanoma nursing services, the establishment of clinical trials in Wagga Wagga, opportunities for melanoma patients within the region to contribute to MIA research, and melanoma education opportunities – both professional (GPs/Clinics) and communitybased through the SunSafe Student Ambassador program.
‘Our shared vision is zero deaths from melanoma, no matter where you live, and this is a fantastic opportunity to enhance the effective delivery of treatment and support services to melanoma patients in this region.’ Annette St Clair, Co-founder of Amie St Clair Melanoma Trust
MIA is also delighted to be merging with melanomaWA, providing increased resources dedicated to reducing the impact of melanoma in Western Australia.
The two highly respected organisations will be working together on a regional and national level regarding awareness, education, support, and research.’ Mr Martin Slabbert, Chairman melanomaWA
Five years ago Julie Randall was diagnosed with melanoma and was given months to live. The melanoma had spread throughout her body. The doctors said it was incurable and she’d be lucky if she survived the next nine months. Julie, a patient at Melanoma Institute Australia under Professor Georgina Long was placed on an experimental drug trial. To watch the entire program, visit 9now.com or click here.
Meet our latest Surgical Oncology Fellow, Eva Nagy, to find out more about life as a surgical oncologist, why she came to MIA and what she hopes to achieve.
Melanoma research at ASCO this year focussed on the more precise use of current treatments to ensure optimal treatment for each patient.
MIA recently demonstrated that reflectance confocal microscopy is a useful tool in the clinic to diagnose suspicious-looking lesions in the mouth.
New research is likely to change the way melanoma is managed in many patients by reducing the need for major surgery and its associated morbidity and cost.
Researchers from MIA will present their latest research findings to the world’s largest oncology conference in early June.
Australian researchers pioneer life-extending treatment for advanced melanoma patients with brain tumours
Australian researchers are the first to demonstrate that patients with advanced melanoma which has spread to the brain can have increased life expectancy and possibly even beat the disease.
Melanoma March 2017 - that's a wrap! Thank you to everyone that helped make it happen.
Thank you so much to all those who contributed in a variety of ways to Melanoma March 2017 in 17 different locations and more around the country! You have contributed to getting the Big Data for Melanoma national Research Project happening!
By looking at the ‘dark matter’ of the genome, new research has found that genetic changes in acral and mucosal melanoma are completely different to mutations found in skin melanoma.
‘Slip, slop, slap’ is synonymous with being Australian and playing it safe in the sun. These sun smart rules reduce our chances of getting melanoma of the skin. However, new research tells a different story for those affected by rarer forms of melanoma.
Using MIA's patient database, researchers have developed conditional survival estimates for Stage III melanoma patients to more accurately predict survival outcomes.
MIA is proud to be celebrating an important milestone – the 60th anniversary of melanoma research and Australian-led global efforts to find a cure.
Research achievements by MIA were celebrated at the annual Sydney Medical School recently.
In this Global Research Report we showcase advances in medical oncology, reveal unexpected pathology in acral and skin melanoma, and uncover biomarkers and new gene targets for melanoma.
Professor’s Long and Scolyer are well known in the academic community and beloved by their patients. But we wanted to get to know our new Conjoint Medical Directors a little more and hear their plans on making an impact on melanoma.
Wyong Rugby League Club Group has joined forces with Melanoma Institute Australia to help end melanoma for future generations.
Melanoma research has reached a milestone with the 10,000th patient giving their permission for their blood and tissue samples to be used in the world’s largest melanoma biospecimen bank.
MIA's researchers and clinicians are in Seattle, USA, today sharing their research findings at the prestigious Society of Surgical Oncology’s Annual Cancer Symposium.